PROTECTIVE RECONSTITUTION OF THE SCID MOUSE AGAINST REACTIVATION OF TOXOPLASMIC ENCEPHALITIS

被引:16
|
作者
BEAMAN, MH
ARAUJO, FG
REMINGTON, JS
机构
[1] PALO ALTO MED FDN, RES INST, PALO ALTO, CA 94301 USA
[2] STANFORD UNIV, SCH MED, STANFORD, CA USA
来源
JOURNAL OF INFECTIOUS DISEASES | 1994年 / 169卷 / 02期
关键词
D O I
10.1093/infdis/169.2.375
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A SCID mouse model of toxoplasmic encephalitis (TE) is described. Immunologic reconstitution using splenocytes from Toxoplasma gondii-immune allogeneic or nonimmune syngeneic donors was not successful in preventing reactivation of TE in chronically infected SCID mice. Splenocytes from immune syngeneic donors successfully prevented reactivation. Flow cytometry of spleens of transplanted mice demonstrated only transient reconstitution with allogeneic cells, but syngeneic lymphocytes exhibited prolonged engraftment. Reconstitution with syngeneic cells allowed enhanced production of T. gondii-specific antibody. In vitro depletion of CD4(+) and CD8(+) lymphocytes from BALB/c splenocytes before transplantation into infected SCID mice resulted in survival inferior to that of fully reconstituted SCID mice. Depletion of CD4(+) or CD8(+) cells before transplantation did not result in mortality, but transfer of CD4(+)-depleted splenocytes resulted in histologic evidence of reactivation of TE, whereas transfer of CD8(+)-depleted cells did not. This model could be used for study of the pathogenesis of TE and applied to the evaluation of therapies for TE in immunocompromised hosts.
引用
收藏
页码:375 / 383
页数:9
相关论文
共 50 条
  • [1] A NOVEL MURINE MODEL OF TOXOPLASMIC ENCEPHALITIS - EVIDENCE FOR THE IMPORTANCE OF GENETIC BACKGROUND OF DONORS IN PROTECTIVE RECONSTRUCTION OF THE SCID MOUSE
    BEAMAN, MH
    REMINGTON, JS
    CLINICAL RESEARCH, 1992, 40 (02): : A175 - A175
  • [2] IL-4 is protective against development of toxoplasmic encephalitis
    Suzuki, Y
    Yang, Q
    Yang, SM
    Nguyen, N
    Lim, S
    Liesenfeld, O
    Kojima, T
    Remington, JS
    JOURNAL OF IMMUNOLOGY, 1996, 157 (06): : 2564 - 2569
  • [3] Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model
    Dunay, IR
    Heimesaat, MM
    Bushrab, FN
    Müller, RH
    Stocker, H
    Arasteh, K
    Kurowski, M
    Fitzner, R
    Borner, K
    Liesenfeld, O
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 294 : 148 - 148
  • [4] Genes, cells and cytokines in resistance against development of toxoplasmic encephalitis
    Suzuki, Y
    IMMUNOBIOLOGY, 1999, 201 (02) : 255 - 271
  • [5] Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis
    Dunay, IR
    Heimesaat, MM
    Bushrab, FN
    Müller, RH
    Stocker, H
    Arasteh, K
    Kurowski, M
    Fitzner, R
    Borner, M
    Liesenfeld, O
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4848 - 4854
  • [6] An audit of the use of prophylaxis against toxoplasmic encephalitis in HIV disease
    Fox, E
    Dean, G
    de Ruiter, A
    INTERNATIONAL JOURNAL OF STD & AIDS, 1998, 9 (03) : 177 - 179
  • [7] Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in HIV-infected patients
    van Bilsen, Ward P. H.
    van den Berg, Charlotte H. S. B.
    Rijnders, Bart J. A.
    Brinkman, Kees
    Mulder, Jan W.
    Gelinck, Luc B. S.
    Hoepelman, Andy I. M.
    Wit, Ferdinand W. N. M.
    van de Beek, Diederik
    Prins, Jan M.
    AIDS, 2017, 31 (10) : 1415 - 1424
  • [8] Immune Mediators against Toxoplasma Gondii during Reactivation of Toxoplasmic Retinochoroiditis
    Rudziriski, Marcelo
    Arguelles, Carina
    Couto, Cristobal
    Oubina, Jose R.
    Reiria, Silvia
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (06) : 949 - 957
  • [9] Prevention of recrudescent toxoplasmic encephalitis using ponazuril in an immunodeficient mouse model
    Mitchell, Sheila M.
    Zajac, Anne M.
    Kennedy, Tom
    Davis, Wendell
    Dubey, J. P.
    Lindsay, David S.
    JOURNAL OF EUKARYOTIC MICROBIOLOGY, 2006, 53 : S164 - S165
  • [10] Eudragit coated microemulsion for enhanced efficacy of spiramycin against toxoplasmic encephalitis
    Eid, Rania K.
    Arafa, Mona F.
    Ashour, Dalia S.
    Essa, Ebtessam A.
    Zoghroban, Hager S.
    Issa, Yasmine A.
    Nomeir, Hanan M.
    Safia, Hend S. Abo
    El Maghraby, Gamal M.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 69